PCI Biotech Holding Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for PCI Biotech Holding.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 2.7% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
We're Keeping An Eye On PCI Biotech Holding's (OB:PCIB) Cash Burn Rate
Aug 05We Think PCI Biotech Holding (OB:PCIB) Needs To Drive Business Growth Carefully
Apr 21We're Hopeful That PCI Biotech Holding (OB:PCIB) Will Use Its Cash Wisely
Dec 16We're Not Very Worried About PCI Biotech Holding's (OB:PCIB) Cash Burn Rate
Apr 09What Type Of Shareholders Own The Most Number of PCI Biotech Holding ASA (OB:PCIB) Shares?
Feb 15PCI Biotech Holding (OB:PCIB) Is In A Good Position To Deliver On Growth Plans
Dec 22In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as PCI Biotech Holding has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2024 | 6 | -16 | -15 | -15 | N/A |
3/31/2024 | 4 | -18 | -15 | -15 | N/A |
12/31/2023 | 3 | -20 | -15 | -15 | N/A |
9/30/2023 | 3 | -23 | -23 | -23 | N/A |
6/30/2023 | 3 | -29 | -30 | -30 | N/A |
3/31/2023 | 4 | -38 | -43 | -43 | N/A |
12/31/2022 | 5 | -55 | -59 | -59 | N/A |
9/30/2022 | 5 | -73 | -66 | -66 | N/A |
6/30/2022 | 5 | -84 | -70 | -70 | N/A |
3/31/2022 | 6 | -88 | -69 | -69 | N/A |
12/31/2021 | 6 | -88 | -69 | -68 | N/A |
9/30/2021 | 7 | -90 | -68 | -67 | N/A |
6/30/2021 | 7 | -90 | -77 | -76 | N/A |
3/31/2021 | 7 | -100 | -79 | -76 | N/A |
12/31/2020 | 7 | -72 | -81 | -77 | N/A |
9/30/2020 | 8 | -71 | -87 | -81 | N/A |
6/30/2020 | 8 | -64 | -85 | -79 | N/A |
3/31/2020 | 9 | -61 | -93 | -88 | N/A |
12/31/2019 | 9 | -89 | -87 | -82 | N/A |
9/30/2019 | 10 | -68 | -75 | -72 | N/A |
6/30/2019 | 10 | -62 | -62 | -60 | N/A |
3/31/2019 | 10 | -43 | -44 | -44 | N/A |
12/31/2018 | 10 | -35 | -40 | -40 | N/A |
9/30/2018 | 10 | -46 | -34 | -34 | N/A |
6/30/2018 | 10 | -48 | -35 | -35 | N/A |
3/31/2018 | 10 | -48 | N/A | -34 | N/A |
12/31/2017 | 10 | -43 | N/A | -31 | N/A |
9/30/2017 | 10 | -34 | N/A | -34 | N/A |
6/30/2017 | 10 | -33 | N/A | -36 | N/A |
3/31/2017 | 10 | -35 | N/A | -35 | N/A |
12/31/2016 | 10 | -32 | N/A | -36 | N/A |
9/30/2016 | 11 | -34 | N/A | -34 | N/A |
6/30/2016 | 11 | -34 | N/A | -33 | N/A |
3/31/2016 | 10 | -31 | N/A | -34 | N/A |
12/31/2015 | 10 | -32 | N/A | -33 | N/A |
9/30/2015 | 9 | -34 | N/A | -32 | N/A |
6/30/2015 | 8 | -33 | N/A | -32 | N/A |
3/31/2015 | 8 | -34 | N/A | -32 | N/A |
12/31/2014 | 7 | -36 | N/A | -32 | N/A |
9/30/2014 | 8 | -35 | N/A | -35 | N/A |
6/30/2014 | 8 | -33 | N/A | -33 | N/A |
3/31/2014 | 7 | -30 | N/A | -30 | N/A |
12/31/2013 | 7 | -28 | N/A | -29 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if PCIB's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if PCIB's earnings are forecast to grow faster than the Norwegian market
High Growth Earnings: Insufficient data to determine if PCIB's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if PCIB's revenue is forecast to grow faster than the Norwegian market.
High Growth Revenue: Insufficient data to determine if PCIB's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PCIB's Return on Equity is forecast to be high in 3 years time